Cancer Council NSW logo
13 11 20 Information & Support
Give monthly
Menu
  • Cancer Information
    • By cancer type
      • Bowel cancer
      • Blood cancers
      • Breast cancer
      • Lung cancer
      • Melanoma
      • Prostate cancer
      • View 26 other cancers
    • General information
      • What is cancer?
      • When you are first diagnosed
      • Cancer treatment
      • Managing side effects
      • Living well
      • Practical concerns
      • Advanced cancer
    • How can we help you?
      • Carers
      • Family and friends
      • Multilingual cancer information
      • Schools and teachers
    • More resources
      • Understanding Cancer books
      • Podcast: The Thing About Cancer
      • Podcast: The Thing About Advanced Cancer
      • Cancer Information Services
      • Cancer information for Aboriginal & Torres Strait Islander people
  • Get Support
    • How can we help you
      • 13 11 20 – Speak to a cancer professional
      • Connect with others
      • Cancer Counselling
      • Pro Bono Program
      • Financial Assistance
      • Transport to cancer treatment
      • Accommodation during cancer treatment
      • Support for cancer survivors
    • More information
      • Information for health professionals
      • Aboriginal & Torres Strait Islander people
      • Multilingual cancer information
      • LGBTI
      • Cancer and COVID-19 in NSW
      • Webinars
  • Cancer Prevention
    • By topic
      • Alcohol
      • Diet and exercise
      • Screening and early detection
      • Smoking
      • Sun protection
    • Programs
      • SunSmart NSW website
      • Improve your long game
      • Tackling Tobacco
  • Research
    • By Topic
      • Research we conduct
      • Research we fund
      • Information for researchers
      • Community Involvement in Research
    • Quick links
      • Search research by cancer type or topic
      • Research Grant Applications
      • Research Achievements
  • Get Involved
    • How will you get involved
      • Volunteer with us
      • Work with us
      • Fundraise for us
      • Partner with us
      • Campaign with us
      • Shop with us
    • Quick Links
      • Events calendar
      • Request a Cancer Council Talk
      • Share your story
      • Supporter Recognition
  • Donate
    • Donate today
    • Donate monthly
    • Donate in memory
    • Leave a gift in your will
    • More ways to donate
  • Cancer Information
    • By cancer type
      • Bowel cancer
      • Blood cancers
      • Breast cancer
      • Lung cancer
      • Melanoma
      • Prostate cancer
      • View 26 other cancers
    • General information
      • What is cancer?
      • When you are first diagnosed
      • Cancer treatment
      • Managing side effects
      • Living well
      • Practical concerns
      • Advanced cancer
    • How can we help you?
      • Carers
      • Family and friends
      • Multilingual cancer information
      • Schools and teachers
    • More resources
      • Understanding Cancer books
      • Podcast: The Thing About Cancer
      • Podcast: The Thing About Advanced Cancer
      • Cancer Information Services
      • Cancer information for Aboriginal & Torres Strait Islander people
  • Get Support
    • How can we help you
      • 13 11 20 – Speak to a cancer professional
      • Connect with others
      • Cancer Counselling
      • Pro Bono Program
      • Financial Assistance
      • Transport to cancer treatment
      • Accommodation during cancer treatment
      • Support for cancer survivors
    • More information
      • Information for health professionals
      • Aboriginal & Torres Strait Islander people
      • Multilingual cancer information
      • LGBTI
      • Cancer and COVID-19 in NSW
      • Webinars
  • Cancer Prevention
    • By topic
      • Alcohol
      • Diet and exercise
      • Screening and early detection
      • Smoking
      • Sun protection
    • Programs
      • SunSmart NSW website
      • Improve your long game
      • Tackling Tobacco
  • Research
    • By Topic
      • Research we conduct
      • Research we fund
      • Information for researchers
      • Community Involvement in Research
    • Quick links
      • Search research by cancer type or topic
      • Research Grant Applications
      • Research Achievements
  • Get Involved
    • How will you get involved
      • Volunteer with us
      • Work with us
      • Fundraise for us
      • Partner with us
      • Campaign with us
      • Shop with us
    • Quick Links
      • Events calendar
      • Request a Cancer Council Talk
      • Share your story
      • Supporter Recognition
  • Donate
    • Donate today
    • Donate monthly
    • Donate in memory
    • Leave a gift in your will
    • More ways to donate
  • Home
  • Breast cancer
  • Research
  • Stopping breast cancer treatment resistance and relapse

Stopping breast cancer treatment resistance and relapse

Professor Susan Clark
Garvan Institute of Medical Research 2016 - 2018

This project has worked to improve treatments and reduce the major challenge of some breast cancer patients’ resistance to endocrine therapy and relapse

Background

In Australia, breast cancer will affect 1 in 7 women by the time they are 85. About 70% of breast cancers are what is known as estrogen-receptor (ESR1) positive. The majority of women with this type of breast cancer will have endocrine therapy at some stage during their treatment. Endocrine therapy reduces the risk of breast cancer recurring. However, about a third of patients develop resistance to this therapy and relapse within 15 years of first receiving treatment.

In a previous study, Professor Clark and her team identified changes in the chemical modifications of DNA of ESR1 positive breast cancer cells that cause them to be resistant to endocrine therapy.

The research

In this project, the team investigated the DNA chemical or epigenetic changes further. The new data they have gathered about endocrine resistant breast cancer will enable the researchers to develop potential biomarkers to help identify which patients are at high risk of relapse.

Professor Clark and her team also investigated ways of reversing the epigenetic DNA changes to restore treatment sensitivity. They discovered that a drug called Decitabine, commonly used to treat blood born cancers, can partially reverse the epigenetic changes and stop the growth of tumours in pre-clinical models. Their laboratory testing in a small study has shown promising results that using the drug in combination with endocrine therapy can restore the sensitivity of the tumour cells in pre-clinical models to this treatment.

The impact

Endocrine resistant cancer currently represents the most significant challenge in breast cancer treatment. This research has significantly improved knowledge of how and why endocrine resistance can occur, and importantly, provides a new approach to potentially identify those at highest risk. This exciting discovery provides a promising new treatment approach for patients who currently have limited options.

Professor Susan Clark and her team plan to further validate the new treatment regime in pre-clinical models and to utilise these findings to create a future diagnostic test that could be used to monitor treatment response in women during endocrine therapy.

Research team

Professor Susan Clark
Garvan Institute of Medical Research

Associate Professor Clare Stirzaker
Professor Christopher Ormandy
Associate Professor Elgene Lim

Search research
Cancer research depends on your support
Give monthly
Share

Achievements
18 Jun 2020

Addressing the needs of long-term prostate cancer survivors

Find out more
20 May 2020

HPV vaccine linked to decline in premature births

Find out more
Latest news
19 Jul 2021

ROSA – A roadmap for individualised breast screening

Find out more
  • About us
  • News & Media
  • Cancer Council Shop
  • Contact us
  • Work with us
  • Privacy and website policies
Aboriginal Daffodil logo

Cancer Council NSW acknowledges the traditional custodians of the land on which we live and work. We pay our respects to the elders past and present and extend that respect to all other Aboriginal and Torres Strait Islander peoples.

Registered Charity (ACNC)

© Cancer Council NSW 2021. Cancer Council NSW is registered with the Australian Taxation Office as an Income Tax Exempt Charity: Charitable Fundraising Authority No. 18521. ABN 51 116 463 846. Cancer Council NSW, 153 Dowling Street, Woolloomooloo NSW 2011. All donations over $2 are tax deductible.